{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:46:31Z","timestamp":1790379991263,"version":"4.1.0"},"reference-count":43,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["4R00CA153929"],"award-info":[{"award-number":["4R00CA153929"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Salinomycin (Sali) has selective toxicity to cancer stem cells (CSCs), a subpopulation of cancer cells that have been recently linked with tumor multidrug resistance (MDR). To utilize its selective toxicity for cancer therapy, we sought to devise a nanoparticle (NP) carrier to deliver Sali to solid tumors through the enhanced permeability and retention effect and, hence, to increase its exposure to CSCs. First, hydrophobic Sali was conjugated to a hydrophilic, immune-tolerant, elastin-like polypeptide (iTEP); the amphiphilic iTEP\u2013Sali conjugates self-assemble into NPs. Next, free Sali was encapsulated into the NPs alone or with two additives, N,N-dimethylhexylamine (DMHA) and \u03b1-tocopherol. The coencapsulation significantly improved the loading efficiency and release profile of Sali. The resulting NPs of the coencapsulation, termed as iTEP\u2013Sali NP3s, have an in vitro release half-life of 4.1 h, four times longer than iTEP\u2013Sali NP2s, the NPs that have encapsulated Sali only. Further, the NP3 formulation increases the plasma area under curve and the tumor accumulation of Sali by 10 and 2.4 times, respectively. Lastly, these improved pharmacokinetic and tumor accumulation profiles are consistent with a boost of CSC-elimination effect of Sali in vivo. In NP3-treated 4T1 orthotopic tumors, the mean CSC frequency is 55.62%, a significant reduction from the mean frequencies of untreated tumors, 75.00%, or free Sali-treated tumors, 64.32%. The CSC-elimination effect of the NP3 can further translate to a delay of tumor growth. Given the role of CSCs in driving tumor MDR and recurrence, it could be a promising strategy to add the NP3 to conventional cancer chemotherapies to prevent or reverse the MDR.<\/jats:p>","DOI":"10.1021\/mp5002312","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T09:54:44Z","timestamp":1403603684000},"page":"2703-2712","source":"Crossref","is-referenced-by-count":47,"title":["iTEP Nanoparticle-Delivered Salinomycin Displays an\nEnhanced Toxicity to Cancer Stem Cells in Orthotopic Breast Tumors"],"prefix":"10.1021","volume":"11","author":[{"given":"Peng","family":"Zhao","sequence":"first","affiliation":[{"name":"The University of Utah , , 30S 2000E , , ,","place":["Salt Lake City, Utah, United States, 84112"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Dong","sequence":"additional","affiliation":[{"name":"The University of Utah , , 30S 2000E , , ,","place":["Salt Lake City, Utah, United States, 84112"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Duke University , , , ,","place":["Durham, North Carolina, United States, 27708-0271"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingnan","family":"Chen","sequence":"additional","affiliation":[{"name":"The University of Utah , , 30S 2000E , , ,","place":["Salt Lake City, Utah, United States, 84112"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"issue":"7","key":"2026090201223829600_cit1","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective\nidentification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"2026090201223829600_cit2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer\nstem cells\ndictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Todaro","year":"2007","journal-title":"Cell Stem cell"},{"issue":"6","key":"2026090201223829600_cit3","doi-asserted-by":"crossref","first-page":"e2428","DOI":"10.1371\/journal.pone.0002428","article-title":"Colorectal Cancer Stem Cells Are Enriched in Xenogeneic\nTumors Following Chemotherapy","volume":"3","author":"Dylla","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"2026090201223829600_cit4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification\nand expansion of the tumorigenic lung\ncancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ."},{"issue":"7120","key":"2026090201223829600_cit5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells\npromote radioresistance by preferential activation of the DNA damage\nresponse","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"3","key":"2026090201223829600_cit6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification\nof pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"2026090201223829600_cit7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 Regulates Self\nRenewal and Tumorigenicity of Breast Cancer\nCells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"issue":"3","key":"2026090201223829600_cit8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct Populations\nof Cancer Stem Cells Determine Tumor Growth and Metastatic Activity\nin Human Pancreatic Cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"9","key":"2026090201223829600_cit9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0909-1010","article-title":"Cancer\nstem cells: mirage or reality?","volume":"15","author":"Gupta","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"2026090201223829600_cit10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic Resistance of Tumorigenic\nBreast Cancer Cells to Chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Natl.\nCancer Inst."},{"issue":"12","key":"2026090201223829600_cit11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.leu.2401975","article-title":"Proliferative status of primitive hematopoietic progenitors\nfrom patients with acute myelogenous leukemia (AML)","volume":"14","author":"Guan","year":"2000","journal-title":"Leukemia"},{"issue":"9","key":"2026090201223829600_cit12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.onc.1210200","article-title":"Targeted therapy for cancer stem cells: the patched pathway and ABC\ntransporters","volume":"26","author":"Lou","year":"2007","journal-title":"Oncogene"},{"issue":"9","key":"2026090201223829600_cit13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC\ntransporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells\nand is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"issue":"3","key":"2026090201223829600_cit14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V87.3.1097.bloodjournal8731097","article-title":"Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase\ngene transfer","volume":"87","author":"Magni","year":"1996","journal-title":"Blood"},{"issue":"36","key":"2026090201223829600_cit15","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1073\/pnas.0805706105","article-title":"Single-cell\ncloning of colon cancer stem cells reveals a multi-lineage differentiation\ncapacity","volume":"105","author":"Vermeulen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"2026090201223829600_cit16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem\ncells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"2026090201223829600_cit17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","article-title":"Heterogeneity in\nCancer: Cancer Stem Cells versus Clonal Evolution","volume":"138","author":"Shackleton","year":"2009","journal-title":"Cell"},{"issue":"4","key":"2026090201223829600_cit18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of Selective Inhibitors\nof Cancer Stem Cells by High-Throughput Screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"issue":"4","key":"2026090201223829600_cit19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3892\/or.2013.2241","article-title":"Antitumor properties of salinomycin on cisplatin-resistant\nhuman ovarian cancer cells in vitro and in vivo: involvement of p38\nMAPK activation","volume":"29","author":"Zhang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"2","key":"2026090201223829600_cit20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.toxlet.2013.07.022","article-title":"Salinomycin induces\napoptosis in cisplatin-resistant colorectal cancer cells by accumulation\nof reactive oxygen species","volume":"222","author":"Zhou","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"32","key":"2026090201223829600_cit21","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits\nWnt signaling and selectively\ninduces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"2026090201223829600_cit22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2010.03.008","article-title":"The cancer stem cell\nselective inhibitor salinomycin is a p-glycoprotein inhibitor","volume":"45","author":"Riccioni","year":"2010","journal-title":"Blood Cells, Mol., Dis."},{"issue":"2","key":"2026090201223829600_cit23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biomaterials.2011.09.072","article-title":"The eradication of breast cancer and cancer stem cells using octreotide\nmodified paclitaxel active targeting micelles and salinomycin passive\ntargeting micelles","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"2026090201223829600_cit24","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1038\/cddis.2011.46","article-title":"Salinomycin induces\ncalpain and cytochrome c-mediated\nneuronal cell death","volume":"2","author":"Boehmerle","year":"2011","journal-title":"Cell Death Dis."},{"issue":"1190","key":"2026090201223829600_cit25","first-page":"U799","article-title":"A case of human poisoning by salinomycin,\nan agricultural antibiotic","volume":"117","author":"Story","year":"2004","journal-title":"N. Z. Med. J."},{"issue":"7","key":"2026090201223829600_cit26","doi-asserted-by":"crossref","first-page":"e69086","DOI":"10.1371\/journal.pone.0069086","article-title":"Dose-dependent adverse effects of\nsalinomycin on male reproductive organs and fertility in mice","volume":"8","author":"Ojo","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"2026090201223829600_cit27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nmat2569","article-title":"Self-assembling chimeric polypeptide-doxorubicin conjugate\nnanoparticles that abolish tumours after a single injection","volume":"8","author":"MacKay","year":"2009","journal-title":"Nat. Mater."},{"issue":"3","key":"2026090201223829600_cit28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology:\nopportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"2026090201223829600_cit29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/bc300632w","article-title":"Hyaluronic\nacid-based nanogel-drug conjugates with enhanced anticancer activity\ndesigned for the targeting of CD44-positive and drug-resistant tumors","volume":"24","author":"Wei","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"2026090201223829600_cit30","volume-title":"Lab FAQs: Find a Quick Solution","year":"2013","edition":"4"},{"issue":"2","key":"2026090201223829600_cit31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2005.10.008","article-title":"In vitro release\nof the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone)\nmicelles","volume":"110","author":"Forrest","year":"2006","journal-title":"J. Controlled Release"},{"issue":"3","key":"2026090201223829600_cit32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2009.02.024","article-title":"Encapsulation\nof the synthetic retinoids\nAm80 and LE540 into polymeric micelles and the retinoids\u2019 release\ncontrol","volume":"136","author":"Satoh","year":"2009","journal-title":"J. Controlled Release"},{"issue":"10","key":"2026090201223829600_cit33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro\npropagation and transcriptional\nprofiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev."},{"issue":"12 Part 1","key":"2026090201223829600_cit34","first-page":"6387","article-title":"A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy:\nMechanism of Tumoritropic Accumulation of Proteins and the Antitumor\nAgent Smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"3","key":"2026090201223829600_cit35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect:\nUnique features of\ntumor blood vessels for drug delivery, factors involved, and limitations\nand augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Delivery\nRev."},{"issue":"1","key":"2026090201223829600_cit36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/194982411X13003853539948","article-title":"Nanoscale Self-Assembly\nfor Delivery of Therapeutics and Imaging Agents","volume":"13","author":"Chen","year":"2011","journal-title":"Technol. Innovation"},{"issue":"10\u201312","key":"2026090201223829600_cit37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0731-7085(91)80043-9","article-title":"Comparative determination of salinomycin by high-performance\nliquid chromatography, microbiological and calorimetric methods in\ntesting production processes and animal feed preparations","volume":"9","author":"Sokolic\u0301","year":"1991","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"13","key":"2026090201223829600_cit38","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","article-title":"Isolation\nand In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem\/Progenitor\nCell Properties","volume":"65","author":"Ponti","year":"2005","journal-title":"Cancer Res."},{"issue":"19","key":"2026090201223829600_cit39","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin Selectively\nTargets Cancer Stem Cells, and Acts Together with Chemotherapy to\nBlock Tumor Growth and Prolong Remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer\nRes."},{"issue":"31","key":"2026090201223829600_cit40","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1016\/j.biomaterials.2013.06.042","article-title":"The eradication\nof breast cancer cells and stem cells by 8-hydroxyquinoline-loaded\nhyaluronan modified mesoporous silica nanoparticle-supported lipid\nbilayers containing docetaxel","volume":"34","author":"Wang","year":"2013","journal-title":"Biomaterials"},{"issue":"7","key":"2026090201223829600_cit41","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1039\/c2cs15289d","article-title":"Drug development:\nlonger-lived proteins","volume":"41","author":"Kontos","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"11","key":"2026090201223829600_cit42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"De Groot","year":"2007","journal-title":"Trends Immunol."},{"issue":"1\u20133","key":"2026090201223829600_cit43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-3659(97)00115-6","article-title":"Characterization of physical entrapment\nand chemical conjugation of adriamycin in polymeric micelles and their\ndesign for in vivo delivery to a solid tumor","volume":"50","author":"Yokoyama","year":"1998","journal-title":"J. Controlled Release"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/mp5002312","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/11\/8\/2703\/14368201\/mp5002312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/11\/8\/2703\/14368201\/mp5002312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:49Z","timestamp":1788326569000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/11\/8\/2703\/1379260\/iTEP-Nanoparticle-Delivered-Salinomycin-Displays"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,24]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,6,24]]},"published-print":{"date-parts":[[2014,8,4]]}},"URL":"https:\/\/doi.org\/10.1021\/mp5002312","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,24]]}}}